Clovis Oncology reported $34.48M in Trade Debtors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Abbvie ABBV:US $ 10733M 756M
Acadia Pharmaceuticals ACAD:US $ 63.48M 1.86M
Acorda Therapeutics ACOR:US $ 11.99M 5.01M
Agios Pharmaceuticals AGIO:US $ 5.9M 1.53M
Arrowhead Research ARWR:US $ 1.32M 1.17M
Astrazeneca AZN:US 9.05B 1.26B
AstraZeneca AZN:LN 9.05B 1.26B
Cerulean Pharma CERU:US $ 1.15M 989.07K
Clovis Oncology CLVS:US $ 34.48M 0.8M
Esperion Therapeutics ESPR:US 25.12M 2.18M
Halozyme Therapeutics HALO:US $ 113.76M 22.79M
Heron Therapeutics HRTX:US $ 41.1M 5.6M
Insmed INSM:US $ 25.72M 1.37M
Intrexon XON:US $ 21.08M 5.59M
Ligand Pharmaceuticals LGND:US $ 41.8M 49.85M
Merk MRK:US $ 9828M 598M
Novartis NOVN:VX 8.68B 395M